20 June 2013
Keywords: genta, updates, genasense, ph, iii, progress, new
Article | 30 June 2008
New Jersey, USA-based Genta has presented a progress update from an ongoing Phase III trial of Genasense (oblimersen sodium) injection, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 June 2008
19 June 2013
© 2013 thepharmaletter.com